INTRODUCTION
Endometriosis is a multifactorial hormonally related complex disease, characterized by endometrial-like tissue growing outside of the uterus. This ectopic endometrium responds to hormonal signaling and is manifested by dysmenorrhea. One of the most common complications of this disease is reduced fertility and infertility. Although it has been estimated to affect 5% of general population, its prevalence may be as high as 30% in infertile women. [1] Endometrioma usually presents as a pelvic mass arising from the growth of ectopic endometrial tissue within the ovary. The pathogenesis of endometriosis is still unknown.
effects." [4] Among the EDCs, bisphenol A (BPA) is one of the highest volume chemicals produced worldwide and used by the manufacturers of plastics and epoxy resins which are pervasive in our environment and our daily lives. [5] They are used for polycarbonate bottles and containers, food and drink cans, medical devices and dental fillings. It seems that the human exposure to BPA can be through the diet by leaching from plastics containers and lining in cans.
BPA is similar to endogenous estrogen and has the ability to interact with estrogen receptors, stimulate estrogen production, and also alter gonadotropin hormone secretion. [6] [7] [8] The Endocrine Society suggested the strong evidence of EDCs for adverse reproductive outcomes. [6, 9] Meanwhile, several studies confirmed the effects of BPA on reproductive indices. [10] [11] [12] [13] Animal study by Signorile et al. was reported the presence of endometriosis-like phenotype in female offspring of mice exposed to BPA in the uterus, [14] and it supports the embryogenetic pathogenesis of endometriosis.
Previous epidemiological studies evaluating the relationship between urinary or serum BPA concentrations and endometriosis had equivocal results [15] [16] [17] [18] due to critical data gaps and short elimination half-life of BPA.
The possible action of BPA as a toxicant and actual risk for human remains unclear. Hence, further studies are needed. Especially the lack of data about EDCs in women in Iran was the motivation for doing this study.
The aim of our investigation was to evaluate the relationship between BPA levels in urine samples of women with endometrioma who were candidates for operative laparoscopy in comparison to controls.
MATERIALS AND METHODS

Study design and population
This case-control study was approved by the Institutional Review Board of Tehran University of Medical Sciences (No. 18630). We received informed consent from all participants. They were informed that participation included an interview, pelvic and clinical examination, and transvaginal ultrasound.
All cases were selected from women who were referred to gynecology and infertility center with ovarian endometrioma from other centers and were candidates for operative laparoscopy and ovarian cystectomy.
The control group was selected from women who had clinical file in the center due to previous problem and came for routine checkup and Pap smear.
The study samples were interviewed by a trained midwife about basal information and symptoms of endometriosis. All participants had a pelvic examination and transvaginal ultrasound in lithotomic position (HS-2600, Honda Electronic Co., Ltd., Japan) with 12.5 MHz.
After confirmation of the endometrioma in cases, they entered into our study. The control group had no symptom of current or previous endometrioma in clinical and sonographic examination.
Meanwhile, if both groups had no characteristics such as polycystic ovarian syndrome, uterine fibroma, diabetes mellitus, metabolic and endocrine disorders, history of cardiovascular disease, blood pressure more than 140/80 mmHg, renal failure, body mass index (BMI) >30, neoplastic disorders, and smoking, they included in the study.
The participants were asked to collect a first morning urine sample before surgery and any medical intervention. The samples were transferred into a special tube (without BPA compound) within 1 h and stored at −70°C until analysis.
For sample size calculation, we used the Upson et al.'s study [18] that was about the evaluation of BPA and risk of endometriosis. The proportion of controls above the median value was about 50% and we estimated in cases will be about 75%. Therefore, we calculated that fifty samples would be required in each group with a power of 80% and α = 0.05 using the Epi Info website (www.cdc.gov/epiinfo). We collected fifty samples in each group from volunteers living in Tehran (capital city of Iran) from June 2013 to September 2014.
Urinary bisphenol A analysis
The samples were analyzed at Pharmaceutical Science Research Center of Tehran University of Medical Sciences. Total BPA (conjugated and free) in urine was measured using high-performance liquid chromatography (HPLC) based on the modified methods of Yang et al. [19] and He et al. [20] In brief, the reaction mixtures of phosphorous acid buffer, β-glucuronidase (Sigma), and sample aliquots in glass tubes were incubated for hydrolyzation at 37°C and then were extracted twice with ether (HPLC grade, Merck). The supernatants were collected and evaporated with stream of nitrogen gas. The residue was dissolved in 60% acetonitrile (HPLC grade, Merck) and analyzed by HPLC on the following parameters: a KNAUER liquid chromatograph (KNAUER, Germany) with RF-20A prominence fluorescence detector with excitation wavelength 275 nm and emission wavelength 300 nm and a ChromGate software version 3.3 (KNAUER, Germany) used for data processing. Column, Chromolith ® Performance RP18e, 5 µM, liquid chromatography column 100 × 4.6 mm; 20 µl injection loop, mobile phase A and B, acetonitrile/water (40:60, v/v), equivalent grade; and flow: 1.0 mL/min. HPLC water was from Millipore Super-Q Plus Water Purification System (Bedford, MA, USA). The limit of detection (LOD) was calculated with the method recommended by the Environmental Protection Agency (2004). The LODs of BPA in urine were 0.33 µg/L.
Statistical analyses
Statistical analyses were performed using the SPSS software (SPSS, version 16, SPSS, Inc., IL, USA). To estimate the relationship between urinary BPA concentrations and endometriosis, we estimated the odds ratio (OR) and 95% confidence interval (CI) using logistic regression. We perform analysis with adjustment for age, BMI, parity, and education. These variables were selected prior to inclusion on the basis of evidence of an association from the literature. We substituted the concentration of BPA below the LOD by a value equal to the LOD divided by two. Urinary BPA concentration had no normal distribution and showed a right-skewed distribution. Data are expressed as arithmetic and geometric mean ± standard deviation (mean ± SD) and number (percentile). Statistical significance for differences was tested by Student's t-test or Mann-Whitney U-test depends on normal distribution of continuous data. Categorical data differences were compared by Chi-square test. A P < 0.05 was considered statistically significant.
RESULTS
The participants were aged 22-45 years (median, 32). Descriptive analysis of the group characteristics in Table 1 shows that total characteristics of both groups were similar (P > 0.05).
BPA was detected in 86% (43/50) of cases and 82.4% (42/51) of control samples. Based on Table 2 , the mean concentration of BPA was 5.53 ± 3.46 ng/mL and 1.42 ± 1.56 ng/mL in endometrioma and control group, respectively. The differences were statistically significant (P < 0.0001, Mann-Whitney U-test). Geometric mean and geometric SD, median, and interquartile range are manifested in Table 2 .
Logistic regression analysis showed a positive association between endometrioma and BPA level with OR 1.74 (95% CI: 1.40-2.16) after adjustment for age, BMI, parity, and education status. The result of crude OR and adjusted OR was fairly similar [ Table 3 ].
DISCUSSION
In this study, the BPA urinary concentrations among women with endometrioma were statistically higher in compared with control group. Meanwhile, it seems that the confounding factors have not any effect on the result of logistic regression analyses.
The results of the study by Cobellis et al. [17] which was accordant to our result suggested a positive relationship between bisphenol and endometriosis based on the measurement of serum samples. They reported that at least one of the bisphenols (A or B) was found in 63.8% of sera of 58 patients with endometriosis and they did not find BPA in serum samples from healthy women.
However, in the present study, the detection rate of the total urine BPA, in both groups (86% vs. 82.4%), was higher than the study by Cobellis et al. [17] maybe due to differences of type of samples (urine vs. serum).
This supports the hypothesis that BPA is metabolized quickly and excreted in urine without evidence of accumulation within body.
[21] Hence, we believe that measurement of BPA in urine sample provides a better estimation of exposures than measurement of these compounds in serum. This is because of short-lived nature of BPA in serum or plasma and risk of contamination arising during sample collection or analysis.
A major advantage of the study by Cobellis et al. [17] was selection of cases and controls after operative laparoscopy in patients who had evidence of ovarian cysts or chronic pelvic pain and dysmenorrhea. Therefore, study groups' selection was more reliable.
Two previous epidemiologic studies which were measured the BPA in urine samples reported no statistically significant association of urinary BPA concentrations and endometriosis [15, 16] and their results are contradictory with our findings. These differences are due to some factors such as evaluation all type of endometriosis based on their severity without the separation of results based on ovarian and nonovarian endometriosis, laboratory analyses error, and intraindividual variation in BPA exposure.
In a recent study by Upson et al., a statistically significant association between total urinary BPA concentrations and nonovarian endometriosis but not ovarian was reported. [18] These findings are in contrast with our results that show significant association between urinary BPA and endometrioma or ovarian endometriosis.
There is evidence that BPA has adverse effects on the maturing oocytes and meiotic cell division machinery [22] [23] [24] and also may have adverse impact on survival of oocytes, follicle dynamics, ovarian reserve, and infertility in general. [25] However, animal study did not find any endometriosis lesion in ovaries of mice treated with BPA respect to the control. [26] Our data support the idea that exposure to BPA can cause reproductive disorders in women, being the ovary one of the first targets.
As we mentioned, a research group has recently demonstrated the presence of ectopic endometrium in human fetus at different gestational ages and another study revealed that the prenatal exposure of mice to BPA elicits an endometriosis-like phenotype in female offspring. [3, 14] Therefore maybe, exposure to chemicals such as BPA in pregnant women and their fetus causes endometriosis during organogenesis and it manifested during reproductive age. Hence, evaluation of BPA in serum samples of pregnant women and possible transferring to the fetus through placenta should be investigated in a future study.
The results of the present study as the first evaluation of BPA in women's population in Iran manifested higher exposure in endometriosis patients in compared with another study. [15, 16] Hence, more restrict regulation must be designed in our country to prevent the uncontrolled increasing usage of such chemicals, and further investigation is needed to find the origin of these chemicals.
We should also consider that endometriosis is a multifactorial disease with unknown pathogenesis and it is not reliable to conclude only environmental factors such as BPA are the main causative agents.
Our study had some limitations: First, it is possible to confirm ovarian endometriosis by clinical and pelvic examination accompanied by transvaginal ultrasound. However, nonovarian endometriosis can be detected accurately by surgery. We confirmed nonovarian endometriosis in the case group during surgery, but in control selection, it was not feasible to surgically confirm the absence of nonovarian endometriosis because of ethical issue. Second, we did not measure urinary creatinine to evaluate the daily exposure to BPA and urine sample dilution by measuring creatinine has more accurate result. Third, BPA is a nonpersistent chemical with a urinary elimination half-life <6 h [21] and we measured BPA in only one-time urine sample and it should be better to collect 24-h urine sample. More importantly, it would have been better to evaluate BPA exposure before disease onset than at the time of diagnosis or surgery.
Meanwhile, it should be better to evaluate the relationship between environmental chemicals and endometriosis based on severity. Hence, further large-scale studies with more defined population and innovative methodologies are required to be designed to evaluate the association of other category of endometriosis based on the severity and stages.
CONCLUSION
Although the results of this study manifested the significant relationship between BPA concentrations and ovarian endometriosis in subgroup of Iranian women, the exact role of BPA on the reproduction is still not clear and epidemiologic data on human health effects are limited.
